Back to results
US 11,951,091 B2Granted
Complex, contrast agent and method for treating a disease related to CXCR4 receptor
AssigneeInstitute of Nuclear Energy Research, Atomic Energy Council, Executive Yuan, R.O.C.
InventorsChien-Chung Hsia, Chung-Hsin Yeh, Cheng-Liang Peng, Chun-Tang Chen
Life of this patent
Estimating the term…
Abstract
Disclosed herein is a complex, a contrast agent and the method for treating a disease related to CXCR4 receptor. The complex is configured to bind the CXCR4 receptor, and is used as a medicament for diagnosis and treatment of cancers and other indications related to the CXCR4 receptor.
Claims7
A complex configured to bind CXCR4, comprising the following structures:
Dependencies are inferred from the claim text.